| UNITED STATES |
|---|
| SECURITIES AND EXCHANGE COMMISSION |
| Washington, D.C. 20549 |
NOTICE OF EFFECTIVENESS |
| Effective Date: | March 27, 2023 |
|---|---|
| Accession Number: | 0001493152-23-008859 |
| Submission Type: | POS AM |
| CIK: | 0001517681 |
|---|---|
| Company Name: | Propanc Biopharma, Inc. |
| File Number: | 333-238240 |